title: ImmunoPET to help stratify patients for targeted therapies and to improve drug development.
authors.affiliation: Inserm U892, CNRS UMR 6299, University Hospital-ICO-CRCNA, Nantes-Saint-Herblain, France.
authors.forename: Françoise
authors.initials: F
authors.lastname: Kraeber-Bodere
authors.affiliation: Inserm U892, CNRS UMR 6299, University Hospital-ICO-CRCNA, Nantes-Saint-Herblain, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Bailly
authors.affiliation: Inserm U892, CNRS UMR 6299, University Hospital-ICO-CRCNA, Nantes-Saint-Herblain, France.|Groupement d'Intérêt Public Arronax, University of Nantes, Nantes, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Chérel
authors.affiliation: Groupement d'Intérêt Public Arronax, University of Nantes, Nantes, France. chatal@arronax-nantes.fr.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Chatal
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D057054:Molecular Imaging / Q000379:methods; D058990:Molecular Targeted Therapy / Q000379:methods; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000276:immunology* / Q000628:therapy; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D019275:Radiopharmaceuticals